- Pfizer Inc (NYSE: PFE) will begin producing an essential ingredient for its COVID-19 vaccine developed in partnership with BioNTech SE (NASDAQ: BNTX) at a facility in Ireland.
- An existing Pfizer facility in Grange Castle, Dublin, will be adapted to produce the “mRNA drug substance,” a core component in the vaccine, for $40 million, the Irish Times reported.
- Around 75 jobs will also be created.
- Earlier this month, Pfizer lifted its full-year forecasts for revenues from the vaccine to $26 billion from $15 billion, after the sales reached $3.5 billion in the first quarter.
- Last week, the FDA approved the vaccine for 12 to 15-year olds.
- Price Action: PFE shares are down 1.3% at $39.5, and BNTX shares are down 0.9% at $192.8 during the market session on the last check Wednesday.
Hain Celestial To Acquire Clearlake’s ParmCrisps, Thinsters Brands
Clearlake Capital Group, L.P., agreed to sell Proven Brands, Inc. and KTB Foods, Inc. (d/b/a That's How We Roll) to Hain Celestial Group Inc (NASDAQ: HAIN) for approximately $259 million.
